The Health Protection Agency (HPA) has confirmed that no additional cases of meningococcal disease have been reported in the Maldives following an initial case identified on June 25. The agency has been closely monitoring the situation and testing individuals who were in close contact with the infected patient.

According to HPA, 46 individuals identified as close contacts of the meningococcal patient were tested, and no further infections were detected. The agency reassured the public that the situation was under control and that measures were in place to prevent any potential spread of the disease.

Meningococcal disease, which spreads through the respiratory tract, poses a higher risk to those in close proximity to an infected person. Symptoms typically appear between 1 and 10 days after exposure. The HPA emphasized the importance of vigilance and prompt medical attention for individuals showing symptoms of the disease, particularly those who have not received the meningitis vaccine.

The HPA advised pilgrims who have not been vaccinated against meningitis or exhibit disease symptoms within 14 days of vaccination to seek immediate medical attention. The agency highlighted that the meningitis vaccine is an effective preventive measure, taking about two weeks to develop immunity. Vaccination should be administered at least two weeks before potential exposure to ensure adequate protection.